{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:12:09Z","timestamp":1790194329715,"version":"4.1.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000056","name":"National Institute of Nursing Research","doi-asserted-by":"crossref","award":["R01NR017399"],"award-info":[{"award-number":["R01NR017399"]}],"id":[{"id":"10.13039\/100000056","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000056","name":"National Institute of Nursing Research","doi-asserted-by":"crossref","award":["R01NR017399"],"award-info":[{"award-number":["R01NR017399"]}],"id":[{"id":"10.13039\/100000056","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Kidney360"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>Uremic symptoms are common in patients with kidney failure, but the chemicals causing them are unknown.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>We used state-of-the-art untargeted metabolomics and rigorous analyses to search for metabolites associated with uremic symptoms.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>We identified metabolite-symptom associations but could not replicate findings and offer recommendations for future research.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The specific toxins causing uremic symptoms (nausea, vomiting, pruritus, fatigue, difficulty concentrating, and pain) in kidney failure remain unknown. We used untargeted metabolomics to identify plasma metabolites associated with uremic symptoms in patients receiving hemodialysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We measured metabolites in plasma samples from Longitudinal US\/Canada Incident Dialysis study participants at baseline (discovery;\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      =636) and year 1 (internal validation;\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      =260) and from Frailty Assessment in Renal Disease study participants (external validation;\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      =355). We used metabolite-wise linear models with empirical Bayesian inference to evaluate the association between metabolites and uremic symptom severity, adjusting for key covariates. We accounted for multiple testing using a false discovery rate (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      values adjusted for false discovery rate [pFDR]) for linear models and used two machine learning models to evaluate the association consistency. We defined association as significant if pFDR &lt; 0.1 and consistent if it had medium or high importance in both machine learning models.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Participants had a mean age of 63 years, with uremic symptom prevalence ranging from 44% to 83%. We identified 627 previously characterized (known) and 35,558 unknown metabolite peaks. No known metabolites were significantly and consistently associated with uremic symptom severity across all cohorts. Within cohorts, retinol was negatively associated with nausea\/vomiting in Longitudinal US\/Canada Incident Dialysis at year 1, and indole-3-propionic acid was negatively associated with anorexia in Frailty Assessment in Renal Disease. Several unknown metabolites were associated with symptoms (lowest pFDR, 0.0004), but none were consistent across cohorts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We identified metabolites associated with uremic symptom severity, although findings were inconsistent across cohorts. This study highlights the need for additional research on uremic toxins and clinical outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.34067\/kid.0000000838","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:00:29Z","timestamp":1758643229000},"page":"353-361","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["A Metabolomics Approach To Identify Metabolites Associated with Uremic Symptoms in Patients Receiving Maintenance Hemodialysis"],"prefix":"10.34067","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3420-5859","authenticated-orcid":false,"given":"Solaf","family":"Al Awadhi","sequence":"first","affiliation":[{"name":"Houston Methodist Hospital, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2478-0331","authenticated-orcid":false,"given":"Leslie","family":"Myint","sequence":"additional","affiliation":[{"name":"Mathematics, Statistics, and Computer Science, Macalester College, Saint Paul, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4471-9565","authenticated-orcid":false,"given":"Eliseo","family":"Guallar","sequence":"additional","affiliation":[{"name":"Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8259-9245","authenticated-orcid":false,"given":"Clary B.","family":"Clish","sequence":"additional","affiliation":[{"name":"Broad Institute of MIT and Harvard, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4832-0209","authenticated-orcid":false,"given":"Kendra E.","family":"Wulczyn","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1746-5790","authenticated-orcid":false,"given":"Sahir","family":"Kalim","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Thandhani","sequence":"additional","affiliation":[{"name":"Research, Education, and Clinical Care, Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1924-4801","authenticated-orcid":false,"given":"Dorry L.","family":"Segev","sequence":"additional","affiliation":[{"name":"NYU Langone Health, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3013-925X","authenticated-orcid":false,"given":"Mara","family":"McAdams-DeMarco","sequence":"additional","affiliation":[{"name":"NYU Langone Health, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3562-9725","authenticated-orcid":false,"given":"Sharon M.","family":"Moe","sequence":"additional","affiliation":[{"name":"Indiana University School of Medicine, Indianapolis, Indiana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjani N.","family":"Moorthi","sequence":"additional","affiliation":[{"name":"Indiana University School of Medicine, Indianapolis, Indiana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3319-1224","authenticated-orcid":false,"given":"Jonathan","family":"Himmelfarb","sequence":"additional","affiliation":[{"name":"Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2347-3620","authenticated-orcid":false,"given":"Neil R.","family":"Powe","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California San Francisco, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0846-3187","authenticated-orcid":false,"given":"Marcello","family":"Tonelli","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4797-3200","authenticated-orcid":false,"given":"Eugene P.","family":"Rhee","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7222-4666","authenticated-orcid":false,"given":"Tariq","family":"Shafi","sequence":"additional","affiliation":[{"name":"Baylor Scott & White Health, Temple, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,9,23]]},"reference":[{"issue":"2","key":"B1-20260226","doi-asserted-by":"crossref","first-page":"86","DOI":"10.34067\/KID.0000072019","article-title":"Prevalence and persistence of uremic symptoms in incident dialysis patients","volume":"1","author":"Rhee","year":"2020","journal-title":"Kidney360."},{"issue":"5","key":"B2-20260226","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1007\/s40620-022-01313-0","article-title":"Dialysis symptom index burden and symptom clusters in a prospective cohort of dialysis patients","volume":"35","author":"You","year":"2022","journal-title":"J Nephrol."},{"issue":"7","key":"B3-20260226","first-page":"e5178","article-title":"Uremic pruritus: prevalence and impact on quality of life and depressive symptoms in hemodialysis patients","volume":"11","author":"Satti","year":"2019","journal-title":"Cureus."},{"issue":"6","key":"B4-20260226","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1007\/s11845-023-03393-8","article-title":"Uremic pruritus: prevalence, determinants, and its impact on health-related quality of life and sleep in Indian patients undergoing hemodialysis","volume":"192","author":"Shetty","year":"2023","journal-title":"Ir J Med Sci."},{"key":"B5-20260226","doi-asserted-by":"crossref","first-page":"100064","DOI":"10.1016\/j.sleepx.2023.100064","article-title":"Relationship of sleep duration and sleep quality with health-related quality of life in patients on hemodialysis in Neyshabur","volume":"5","author":"Hosseini","year":"2023","journal-title":"Sleep Med X."},{"issue":"4","key":"B6-20260226","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1046\/j.1525-139X.2001.00072.x","article-title":"Uremic toxicity: urea and beyond","volume":"14","author":"Depner","year":"2001","journal-title":"Semin Dial."},{"issue":"5","key":"B7-20260226","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.transproceed.2015.04.032","article-title":"Kidney transplantation is superior to hemodialysis and peritoneal dialysis in terms of cognitive function, anxiety, and depression symptoms in chronic kidney disease","volume":"47","author":"Ozcan","year":"2015","journal-title":"Transplant Proc."},{"issue":"4","key":"B8-20260226","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.transproceed.2007.03.097","article-title":"Evaluation of effect of renal transplantation in treatment of restless legs syndrome","volume":"39","author":"Azar","year":"2007","journal-title":"Transplant Proc."},{"issue":"2","key":"B9-20260226","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1053\/j.ajkd.2004.10.007","article-title":"Restless Legs Syndrome in patients after renal transplantation","volume":"45","author":"Molnar","year":"2005","journal-title":"Am J Kidney Dis."},{"issue":"3","key":"B10-20260226","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1093\/ndt\/gfq476","article-title":"Sleep disorders, depressive symptoms and health-related quality of life\u2014a cross-sectional comparison between kidney transplant recipients and waitlisted patients on maintenance dialysis","volume":"26","author":"Kovacs","year":"2011","journal-title":"Nephrol Dial Transplant."},{"issue":"7","key":"B11-20260226","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1681\/ASN.2011121175","article-title":"Normal and pathologic concentrations of uremic toxins","volume":"23","author":"Duranton","year":"2012","journal-title":"J Am Soc Nephrol."},{"issue":"2","key":"B12-20260226","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.kint.2021.10.035","article-title":"A metabolomics approach identified toxins associated with uremic symptoms in advanced chronic kidney disease","volume":"101","author":"Hu","year":"2022","journal-title":"Kidney Int."},{"issue":"1","key":"B13-20260226","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1053\/j.ajkd.2023.11.013","article-title":"Metabolites associated with uremic symptoms in patients with CKD: findings from the chronic renal insufficiency cohort (CRIC) study","volume":"84","author":"Wulczyn","year":"2024","journal-title":"Am J Kidney Dis."},{"issue":"1","key":"B14-20260226","first-page":"4351674","article-title":"UPLC-QTOF MS-based serum metabolomic profiling analysis reveals the molecular perturbations underlying uremic pruritus","volume":"2018","author":"Wu","year":"2018","journal-title":"Biomed Res Int."},{"issue":"12","key":"B15-20260226","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1681\/ASN.2016010039","article-title":"Metabolic profiling of impaired cognitive function in patients receiving dialysis","volume":"27","author":"Kurella Tamura","year":"2016","journal-title":"J Am Soc Nephrol."},{"issue":"2","key":"B16-20260226","doi-asserted-by":"crossref","first-page":"e0246765","DOI":"10.1371\/journal.pone.0246765","article-title":"Metabolomic analysis of uremic pruritus in patients on hemodialysis","volume":"16","author":"Bolanos","year":"2021","journal-title":"PLoS One."},{"issue":"7","key":"B17-20260226","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.2215\/CJN.19031220","article-title":"Kidney disease symptoms before and after kidney transplantation","volume":"16","author":"Taylor","year":"2021","journal-title":"Clin J Am Soc Nephrol."},{"issue":"10","key":"B18-20260226","doi-asserted-by":"crossref","first-page":"e296","DOI":"10.1371\/journal.pmed.0040296","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"4","author":"von Elm","year":"2007","journal-title":"PLoS Med."},{"issue":"20","key":"B19-20260226","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1093\/bioinformatics\/btu423","article-title":"Intensity drift removal in LC\/MS metabolomics by common variance compensation","volume":"30","author":"Fern\u00e1ndez-Albert","year":"2014","journal-title":"Bioinformatics."},{"issue":"5","key":"B20-20260226","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3390\/metabo13050665","article-title":"Instrumental drift in untargeted metabolomics: optimizing data quality with intrastudy QC samples","volume":"13","author":"M\u00e4rtens","year":"2023","journal-title":"Metabolites."},{"issue":"7","key":"B21-20260226","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1021\/ac502439y","article-title":"Statistical methods for handling unwanted variation in metabolomics data","volume":"87","author":"De Livera","year":"2015","journal-title":"Anal Chem."},{"key":"B22-20260226","article-title":"BRITS: bidirectional recurrent imputation for time series","author":"Cao","year":"2018","journal-title":"arXiv."},{"issue":"1","key":"B23-20260226","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41598-017-19120-0","article-title":"Missing value imputation approach for mass spectrometry-based metabolomics data","volume":"8","author":"Wei","year":"2018","journal-title":"Sci Rep."},{"issue":"1","key":"B24-20260226","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/bioinformatics\/btr597","article-title":"MissForest\u2014non-parametric missing value imputation for mixed-type data","volume":"28","author":"Stekhoven","year":"2012","journal-title":"Bioinformatics."},{"key":"B25-20260226","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.euprot.2015.02.002","article-title":"Detecting significant changes in protein abundance","volume":"7","author":"Kammers","year":"2015","journal-title":"EuPA Open Proteom."},{"issue":"7","key":"B26-20260226","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3390\/metabo9070143","article-title":"Statistical workflow for feature selection in human metabolomics data","volume":"9","author":"Antonelli","year":"2019","journal-title":"Metabolites."},{"issue":"suppl 2","key":"B27-20260226","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1186\/1753-6561-6-S2-S10","article-title":"Genomic selection using regularized linear regression models: ridge regression, lasso, elastic net and their extensions","volume":"6","author":"Ogutu","year":"2012","journal-title":"BMC Proc."},{"key":"B28-20260226","doi-asserted-by":"crossref","first-page":"Article3","DOI":"10.2202\/1544-6115.1027","article-title":"Linear models and empirical bayes methods for assessing differential expression in microarray experiments","volume":"3","author":"Smyth","year":"2004","journal-title":"Stat Appl Genet Mol Biol."},{"issue":"6","key":"B31-20260226","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.21037\/jtd.2017.05.34","article-title":"A general introduction to adjustment for multiple comparisons","volume":"9","author":"Chen","year":"2017","journal-title":"J Thorac Dis."},{"issue":"6","key":"B33-20260226","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1016\/j.clnu.2018.11.029","article-title":"Clinical association between the metabolite of healthy gut microbiota, 3-indolepropionic acid and chronic kidney disease","volume":"38","author":"Sun","year":"2019","journal-title":"Clin Nutr."},{"issue":"1","key":"B34-20260226","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3390\/nu15010151","article-title":"Extensive summary of the important roles of indole propionic acid, a gut microbial metabolite in host health and disease","volume":"15","author":"Jiang","year":"2022","journal-title":"Nutrients."},{"issue":"4","key":"B35-20260226","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1161\/CIRCRESAHA.123.322381","article-title":"Indole-3-Propionic acid protects against heart failure with preserved ejection fraction","volume":"134","author":"Wang","year":"2024","journal-title":"Circ Res."},{"issue":"3","key":"B36-20260226","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3390\/toxins14030221","article-title":"What if not all metabolites from the uremic toxin generating pathways are toxic? A hypothesis","volume":"14","author":"Vanholder","year":"2022","journal-title":"Toxins."},{"issue":"31","key":"B37-20260226","doi-asserted-by":"crossref","first-page":"22141","DOI":"10.1016\/S0021-9258(18)41646-8","article-title":"On the mechanisms of the formation of L-alloisoleucine and the 2-hydroxy-3-methylvaleric acid stereoisomers from L-isoleucine in maple syrup urine disease patients and in normal humans","volume":"267","author":"Mamer","year":"1992","journal-title":"J Biol Chem."},{"issue":"1","key":"B38-20260226","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1023\/A:1014004414733","article-title":"Stimulation of lipid peroxidation in vitro in rat brain by the metabolites accumulating in maple syrup urine disease","volume":"17","author":"Fontella","year":"2002","journal-title":"Metab Brain Dis."},{"issue":"D1","key":"B39-20260226","doi-asserted-by":"crossref","first-page":"D622","DOI":"10.1093\/nar\/gkab1062","article-title":"Hmdb 5.0: the human metabolome Database for 2022","volume":"50","author":"Wishart","year":"2022","journal-title":"Nucleic Acids Res."}],"container-title":["Kidney360"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000000838","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:03:29Z","timestamp":1786478609000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000000838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,23]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.34067\/kid.0000000838","relation":{},"ISSN":["2641-7650"],"issn-type":[{"value":"2641-7650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,23]]},"assertion":[{"value":"2025-03-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}